OTCMKTS:BCYP Big Cypress Acquisition (BCYP) Stock Price, News & Analysis → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free BCYP Stock Alerts $8.44 -2.01 (-19.23%) (As of 10/22/2021) Add Compare Share Share Today's Range$8.21▼$12.9050-Day Range$8.44▼$8.4452-Week Range$8.21▼$12.90Volume15.34 million shsAverage Volume160,982 shsMarket Capitalization$124.84 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Big Cypress Acquisition alerts: Email Address Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. About Big Cypress Acquisition Stock (OTCMKTS:BCYP)Big Cypress Acquisition Corp. does not have significant operations. The company intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or similar business combination. It primarily focuses in the life science sector. The company was incorporated in 2020 and is based in Miami Beach, Florida.Read More BCYP Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BCYP Stock News HeadlinesApril 24, 2024 | americanbankingnews.comBig Cypress Acquisition (OTCMKTS:BCYP) Share Price Passes Below 200 Day Moving Average of $8.44April 16, 2024 | americanbankingnews.comBig Cypress Acquisition (OTCMKTS:BCYP) Share Price Crosses Above 50-Day Moving Average of $8.44April 25, 2024 | WealthPress (Ad)$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…November 13, 2023 | foxnews.comFlorida men capture massive 17-foot, 200-pound invasive python in EvergladesOctober 15, 2023 | thestreet.comSolar Stock Losers in Sharp's Big U.S. AcquisitionSeptember 10, 2023 | usatoday.comBig 12 college football conference preview: Oklahoma, Texas ready to ride off into sunsetAugust 18, 2023 | finance.yahoo.comBig Ridge Gold Completes Acquisition of Gold Island Inc. Creating a Premier Newfoundland Based Exploration CompanyApril 4, 2023 | forbes.comBig Ass FansApril 25, 2024 | Priority Gold (Ad)Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.March 2, 2022 | reuters.comSAB Biotherapeutics IncOctober 21, 2021 | finance.yahoo.comBig Cypress Acquisition Corp. Stockholders Approve Business Combination with SAB BiotherapeuticsOctober 4, 2021 | finance.yahoo.comSAB Biotherapeutics Announces First Patient Dosed in Phase 3 NIH ACTIV-2 Trial Evaluating SAB-185 for Treatment of COVID-19September 28, 2021 | finance.yahoo.comSAB Biotherapeutics Appoints Russell Beyer Chief Financial OfficerSeptember 24, 2021 | finance.yahoo.comSAB Biotherapeutics Announces SAB-185 Receives Positive DSMB Review and Advances to Phase 3 in NIH-Sponsored ACTIV-2 Trial for Treatment of COVID-19September 22, 2021 | finance.yahoo.comSAB Biotherapeutics Awarded Additional $60.5M from BARDA and U.S. Department of Defense for Rapid Response Capability and Advancing SAB-185 for Treatment of COVID-19September 15, 2021 | finance.yahoo.comSAB Biotherapeutics Announces Completion of Enrollment in Phase 2a Challenge Trial of SAB-176 for the Treatment of Seasonal InfluenzaSeptember 8, 2021 | finance.yahoo.comSAB Biotherapeutics to Present at Upcoming September Virtual Investor ConferencesAugust 11, 2021 | barrons.comBig Cypress Acquisition Corp.August 11, 2021 | finance.yahoo.comSAB Biotherapeutics Announces Nonclinical Data Demonstrating SAB-185 Potently Neutralizes Delta and Lambda SARS-CoV-2 VariantsAugust 10, 2021 | nasdaq.comBig Cypress Acquisition Corp. Common stock (BCYP)See More Headlines Receive BCYP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Big Cypress Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/11/2014Today4/25/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biological Products, Except Diagnostic Sub-IndustryN/A Current SymbolOTCMKTS:BCYP CUSIPN/A CIK1399587 Webwww.bluecalypso.com Phone305-204-3338FaxN/AEmployees5Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio6.13 Quick Ratio6.13 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares14,792,000Free FloatN/AMarket Cap$124.84 million OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Samuel J. Reich (Age 46)CEO, CFO & Director Key CompetitorsCardiol TherapeuticsNASDAQ:CRDLOmega TherapeuticsNASDAQ:OMGAVaxartNASDAQ:VXRTAgenusNASDAQ:AGENDBV TechnologiesNASDAQ:DBVTView All Competitors BCYP Stock Analysis - Frequently Asked Questions How have BCYP shares performed in 2024? Big Cypress Acquisition's stock was trading at $8.44 at the start of the year. Since then, BCYP shares have increased by 0.0% and is now trading at $8.44. View the best growth stocks for 2024 here. How were Big Cypress Acquisition's earnings last quarter? Big Cypress Acquisition Corp. (OTCMKTS:BCYP) posted its earnings results on Tuesday, November, 11th. The technology company reported ($0.01) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.01). The technology company had revenue of $0.31 million for the quarter, compared to analyst estimates of $0.21 million. What other stocks do shareholders of Big Cypress Acquisition own? Based on aggregate information from My MarketBeat watchlists, some companies that other Big Cypress Acquisition investors own include Co-Diagnostics (CODX), iBio (IBIO), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Ascent Solar Technologies (ASTI), BioRestorative Therapies (BRTX), Digital Ally (DGLY) and FuelCell Energy (FCEL). How do I buy shares of Big Cypress Acquisition? Shares of BCYP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BCYP) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Big Cypress Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
